SOX10 can be used as a serum biomarker to increase the efficacy of GPM6B and COL9A3 in the diagnosis of basal breast cancer and the prognosis of patients, which was mainly related to its function on the proliferation of breast tumor cell [31]. The gene discussed is COL9A3; the disease is breast neoplasm.